Getting a new product to market is expensive. There are a variety of studies and research that point to a wide array of costs, but generally speaking, it costs nearly $3 billion dollars to bring a new drug to market. Yes, you read that correctly. Beyond this, the success rate of a new compound to...
Running a Study
Why use EDC if eSource has the endpoint data? In the CRIO article, Automate the protocol with eSource, we described how CRIO eSource automates the protocol, building compliance at the point of capture. CRIO is often asked if we can send the data to the EDC. The answer is yes, if the EDC system’s API...
CRIO Company News
BOSTON, MA – August 9, 2022 – CRIO, a Boston-based healthcare technology company streamlining clinical trials for sponsors, sites and patients, announced that it has reached another milestone, exceeding 2,000 clinical research sites standardizing on CRIO’s eSource platform. CRIO supports a variety of clinical trial data. To date, over 800 life science sponsors have data...
CRIO Company News
CRIO, the leader in eSource technology, is announcing the launch of an industry first, CRIO Reviewer, designed to create a fully integrated eSource/EDC system. Reviewer allows sponsors and CROs to review, query, extract, code and lock data collected in the CRIO eSource application within minutes of site completion. This solution enables research sites to capture...
